Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection

NCT01628744 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-06-27

No results posted yet for this study

Summary

In adult, the prevalence of mycobacterial infections is increased with age is largely unknown. IFN-gamma-IL-12/23 axis or NF-kappaB pathways might also plays crucial roles in adult against mycobacteria. Based on this hypothesis, the investigators had applied a functional assay to these pathways in patients with mycobacterial infection.

Conditions

  • Mycobacterium Infection

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Cheng-Lung KU, Ph.D · Graduate Institute of clinical Medical Science, China Medical Univerity, Taiwan

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Completion
2014-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01628744 on ClinicalTrials.gov